- Home
- /Nicotine
Nicotine
Qualitatively detects the presence of nicotine or its metabolites in a specimen.
Why This Biomarker Matters
Confirms recent nicotine exposure and may impact insurance rates, employment eligibility, or help monitor adherence to smoking cessation efforts.
Overview
This qualitative test detects the presence or absence of nicotine in a biological specimen, commonly used in urine or saliva screening. The test identifies nicotine metabolites to verify tobacco or nicotine product use. It is employed for employment screening, insurance underwriting, monitoring compliance with smoking cessation programs, or clinical assessment of nicotine exposure. A positive result indicates recent nicotine exposure from cigarettes, vaping, patches, or other nicotine-containing products.
Research & Evidence
478 publications
Research data from MEDLINE/PubMed · 478 articles
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
55557-3Primary3854-743830-943195-755558-112294-53853-94350-540386-540385-759936-559937-360320-980541-640387-387596-3Provider Perspectives
Clinical perspectives from verified healthcare providers on Nicotine.
Available Lab Tests
Order tests that measure this biomarker